Osteopore secures Singapore and Vietnam market approvals
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Osteopore Ltd. has secured market approvals in Singapore and Vietnam for its orthopaedic products, including a suite of off-the-shelf and customisable implants. This expansion into Singapore and Vietnam is expected to leverage existing sales channels and accelerate market access for Osteopore's innovative products.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Osteopore
- Prospectus for Renounceable Rights Issue
- OSX Entitlement Offer to support growth
- Activities Update Qtr Ending December 2023 and Appendix 4C
- Notice of General Meeting
- Osteopore signs Bridging Loan agreement
Later from Osteopore
- Update to Replacement Prospectus for Entitlement Offer
- Replacement Prospectus for Renounceable Rights Issue
- Osteopore extends Bridging Loan maturity date
- Response to ASX Query Letter
- Reinstatement to Official Quotation
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore